853 related articles for article (PubMed ID: 30646072)
1. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
2. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
[TBL] [Abstract][Full Text] [Related]
3. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
4. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
5. How Often Are Drugs Made Available Under the Food and Drug Administration's Expanded Access Process Approved?
McKee AE; Markon AO; Chan-Tack KM; Lurie P
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S136-S142. PubMed ID: 28921646
[TBL] [Abstract][Full Text] [Related]
6. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
7. Implementation of 21st Century Cures Act Expanded Access Policies Requirements.
Kang S; Chang S; Ross JS; Miller JE
Clin Pharmacol Ther; 2021 Dec; 110(6):1579-1584. PubMed ID: 34431083
[TBL] [Abstract][Full Text] [Related]
8. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
Chapman CR; Eckman J; Bateman-House AS
Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
[TBL] [Abstract][Full Text] [Related]
9. Patient advocacy organizations' information for patients on pre-approval access to investigational treatments.
Folkers KM; Leone S; Caplan A
BMC Res Notes; 2019 Oct; 12(1):706. PubMed ID: 31661023
[TBL] [Abstract][Full Text] [Related]
10. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
11. Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program.
Speers MA
Pharmaceut Med; 2019 Apr; 33(2):89-98. PubMed ID: 31933253
[TBL] [Abstract][Full Text] [Related]
12. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
Finkelstein PE
AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
[No Abstract] [Full Text] [Related]
13. Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.
Skydel JJ; Luxkaranayagam AT; Dhruva SS; Ross JS; Wallach JD
JAMA Netw Open; 2019 May; 2(5):e193410. PubMed ID: 31074812
[TBL] [Abstract][Full Text] [Related]
14. Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
Stout J; Smith C; Buckner J; Adjei AA; Wentworth M; Tilburt JC; Master Z
PLoS One; 2021; 16(12):e0261478. PubMed ID: 34919568
[TBL] [Abstract][Full Text] [Related]
15. Single-patient expanded access: A primer for pharmacists.
Smith AJF; Redic KA
Am J Health Syst Pharm; 2022 Nov; 79(23):2118-2127. PubMed ID: 36056791
[TBL] [Abstract][Full Text] [Related]
16. Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".
Van Norman GA
JACC Basic Transl Sci; 2018 Apr; 3(2):280-293. PubMed ID: 30062214
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Publicly Available Expanded Access Policies.
Jung E; Zettler PJ; Kesselheim AS
Clin Pharmacol Ther; 2018 Nov; 104(5):1016-1021. PubMed ID: 29271014
[TBL] [Abstract][Full Text] [Related]
18. AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.
J Manag Care Spec Pharm; 2017 Jan; 23(1):105-112. PubMed ID: 28025919
[TBL] [Abstract][Full Text] [Related]
19. Expanded Access and Right To Try Requests: The Community Oncologist's Experience.
Zettler ME; Jeune-Smith Y; Feinberg BA; Phillips EG; Gajra A
JCO Oncol Pract; 2021 Nov; 17(11):e1719-e1727. PubMed ID: 33886355
[TBL] [Abstract][Full Text] [Related]
20. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
Bateman-House A; Robertson CT
JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
